Home>>Signaling Pathways>> Immunology/Inflammation>> Innate Immunity>>Sydowinin B

Sydowinin B (Synonyms: MS-347b)

Catalog No.GC48764

A xanthone polyketide with immunosuppressant activity

Products are for research use only. Not for human use. We do not sell to patients.

Sydowinin B Chemical Structure

Cas No.: 58450-00-3

Size Price Stock Qty
250µg
$255.00
In stock
1mg
$918.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Sydowinin B is a xanthone polyketide that has been found in A. sydowii and has immunosuppressant activity.1 It inhibits LPS- or concanavalin A-induced proliferation of isolated mouse splenic lymphocytes (IC50s = 19.2 and 20.8 µg/ml, respectively).2 Sydowinin B inhibits superoxide generation in, and elastase release from, isolated human neutrophils induced by cytochalasin B and N-Formyl-Met-Leu-Phe with IC50 values of 21.2 and 12.62 µM, respectively.3

1.Hamasaki, T., Sato, Y., and Hatsuda, Y.Structure of sydowinin A, sydowinin B, and sydowinol, metabolites from Aspergillus sydowiAgr. Biol. Chem.39(12)2341-2345(1975) 2.Liu, H., Chen, S., Liu, W., et al.Polyketides with immunosuppressive activities from mangrove endophytic fungus Penicillium sp. ZJ-SY2Mar. Drugs14(12)217(2016) 3.Chung, Y.-M., Wei, C.-K., Chuang, D.-W., et al.An epigenetic modifier enhances the production of anti-diabetic and anti-inflammatory sesquiterpenoids from Aspergillus sydowiiBioorg. Med. Chem.21(13)3866-3872(2013)

Reviews

Review for Sydowinin B

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sydowinin B

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.